Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer

doi:10.3748/wjg.v30.i12.1739

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (880)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

600

Figures (1-4)

Tables (1-3)

Sum=737

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=106

Mar 28, 2024 (publication date) through May 11, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Mar 28, 2024; 30(12): 1739-1750
Published online Mar 28, 2024. doi: 10.3748/wjg.v30.i12.1739

Full Size Figure Download Figure

Figure 4 Survival in patients with postoperative recurrence. A: Overall survival (OS) in patients with regional recurrence and distant metastasis; B: Treatment outcome with chemotherapy, radiotherapy-based combination treatment (RCT), and supportive therapy in patients with regional recurrence; C: Treatment outcome with chemotherapy, RCT, and supportive therapy in patients with distant metastasis. RCT: Radiotherapy-based combination therapy.

Citation: Zhang LT, Zhang Y, Cao BY, Wu CC, Wang J. Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer. World J Gastroenterol 2024; 30(12): 1739-1750
URL: https://www.wjgnet.com/1007-9327/full/v30/i12/1739.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i12.1739